Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CASI Pharmaceuticals (CASI) Prepaid Assets (2021 - 2025)

Historic Prepaid Assets for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to $2.6 million.

  • Pharmaceuticals' Prepaid Assets fell 9987.49% to $2.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.6 million, marking a year-over-year decrease of 9987.49%. This contributed to the annual value of $2.9 million for FY2024, which is 9988.72% down from last year.
  • Pharmaceuticals' Prepaid Assets amounted to $2.6 million in Q2 2025, which was down 9987.49% from $2.7 billion recorded in Q1 2025.
  • Over the past 5 years, Pharmaceuticals' Prepaid Assets peaked at $2.7 billion during Q1 2025, and registered a low of $1.7 million during Q4 2021.
  • Moreover, its 5-year median value for Prepaid Assets was $3.0 million (2022), whereas its average is $1.0 billion.
  • As far as peak fluctuations go, Pharmaceuticals' Prepaid Assets crashed by 9988.72% in 2024, and later surged by 13522934.13% in 2025.
  • Over the past 5 years, Pharmaceuticals' Prepaid Assets (Quarter) stood at $1.7 million in 2021, then surged by 76.24% to $3.0 million in 2022, then soared by 85950.42% to $2.6 billion in 2023, then tumbled by 99.89% to $2.9 million in 2024, then fell by 8.59% to $2.6 million in 2025.
  • Its Prepaid Assets was $2.6 million in Q2 2025, compared to $2.7 billion in Q1 2025 and $2.9 million in Q4 2024.